Brief: GSK To Acquire RAPT Therapeutics For $2.2 Bln
20/01/2026 07:17
Jan 20 (Reuters) - GSK plc GSK.L: GSK PLC - GSK TO ACQUIRE RAPT THERAPEUTICS GSK - TO PAY $58 PER SHARE FOR RAPT, EQUITY VALUE $2.2 BILLION GSK - ESTIMATED UPFRONT INVESTMENT IS $1.9 BILLION Source text: ID:nRST5851Pa Further company coverage: GSK.L ((Reuters.Briefs@thomsonreuters.com;))